FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matteo Puntoni

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Immunohistochemistry

Objects

Ships

Co-author Network

Publications

TOP 3
Sara Gandini; Aliana Guerrieri-Gonzaga; Matteo Puntoni; Andrea Decensi
Metformin and breast cancer risk.
Matteo Puntoni; Sandra Salvi; Angelica Sonzogni; Laura Turbino; Silvia Zanardi; Beatrice Gatteschi; Emanuele Meroni; Paolo Michetti; Egle Minetti; Marco Mori; Francesco Munizzi; Alessandra Argusti; Roberto Bandelloni; Roberto Benelli; Simona Boccardo; Daniela Branchi; Gianni Coccia; Cristiano Crosta; Giuseppe de Roberto; Andrea Decensi
A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma.
Arnoldo Piccardo; Matteo Puntoni; Vania Altrinetti; F Arecco; Anselmo Arlandini; Roberto Bandelloni; Manlio Cabria; Stefania Corvisieri; Luca Foppiani; Fabio Orlandi
Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matteo Puntoni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sara Gandini; Aliana Guerrieri-Gonzaga; Matteo Puntoni; Andrea Decensi
Metformin and breast cancer risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(7):973-4.
2013: Matteo Puntoni; Sandra Salvi; Angelica Sonzogni; Laura Turbino; Silvia Zanardi; Beatrice Gatteschi; Emanuele Meroni; Paolo Michetti; Egle Minetti; Marco Mori; Francesco Munizzi; Alessandra Argusti; Roberto Bandelloni; Roberto Benelli; Simona Boccardo; Daniela Branchi; Gianni Coccia; Cristiano Crosta; Giuseppe de Roberto; Andrea Decensi
A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma.
Cancer prevention research (Philadelphia, Pa.) 2013;6(2):74-81.
2013: Arnoldo Piccardo; Matteo Puntoni; Vania Altrinetti; F Arecco; Anselmo Arlandini; Roberto Bandelloni; Manlio Cabria; Stefania Corvisieri; Luca Foppiani; Fabio Orlandi
Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival.
Clinical nuclear medicine 2013;38(1):18-24.
2012: Arnoldo Piccardo; Matteo Puntoni; Giampiero Villavecchia; A Arlandini; P Bianchi; L Calafiore; Luca Foppiani; Alberto Garaventa; G Hanau; Manlio Cabria
Role of low-cost thyroid follow-up in children treated with radiotherapy for primary tumors at high risk of developing a second thyroid tumor.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2012;56(5):459-67.
2012: Bernardo Bonanni; Paolo Bruzzi; Massimiliano Cazzaniga; Valentina Aristarco; Fabio Bassi; Viviana Galimberti; Alessandra Gennari; Aliana Guerrieri-Gonzaga; Harriet Johansson; Matteo Lazzeroni; Alberto Luini; Giancarlo Pruneri; Matteo Puntoni; Davide Serrano; Maria Stella Trabacca; Clara Varricchio; Paolo Veronesi; Giuseppe Viale; Andrea Decensi
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(21):2593-600.
2012: Carlotta Defferrari; Alessandra Gennari; A Gozza; Rita Lionetto; Ambra Pasa; Arnoldo Piccardo; Matteo Puntoni; Daniela Rosselli; Silvia Zanardi; Michela Bandelloni; Ennio Biscaldi; Sara Campora; Mauro D'Amico; Andrea Decensi
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer.
Journal of ovarian research 2012;5(1):17.
2012: Andrea Decensi; Barbara K Dunn; Alessandra Gennari; Matteo Puntoni; Leslie G Ford
Exemestane for breast cancer prevention: a critical shift?
Cancer discovery 2012;2(1):25-40.
2011: Matteo Lazzeroni; Matteo Puntoni; Bernardo Bonanni; Sara Gandini; Alessandra Gennari; Andrea Decensi
The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it.
Breast (Edinburgh, Scotland) 2011;20 Suppl 3():S36-41.
2011: Andrea Decensi; Maria Cristina Dotti; Viviana Galimberti; Aliana Guerrieri-Gonzaga; Harriet Johansson; Matteo Lazzeroni; Alberto Luini; Debora Macis; Oriana Pala; Giancarlo Pruneri; Matteo Puntoni; Davide Serrano; Paolo Veronesi; Giuseppe Viale; Bernardo Bonanni
Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial.
Cancer prevention research (Philadelphia, Pa.) 2011;4(8):1181-9.
2011: Alberto Tagliafico; Gabriella Baio; Massimo Calabrese; Carlo Emanuele Neumaier; Daniele Pace; Matteo Puntoni; Carlo Martinoli
Brachial plexus MR imaging: accuracy and reproducibility of DTI-derived measurements and fibre tractography at 3.0-T.
European radiology 2011;21(8):1764-71.
2010: Roberto Puzone; Laura Paleari; Franco Montefiore; Luca Ruggiero; Matteo Puntoni; Massimo Maffezzini; Barbara Bobbio; Paola Marroni; Roberta Libener; Pier Giacomo Betta
Osteopontin plasma level does not detect prostate cancer in patients referred for diagnostic prostate biopsy.
The International journal of biological markers 2010;25(4):200-6.
2010: Alberto Stefano Tagliafico; Pietro Ameri; Marta Bovio; Matteo Puntoni; Enrico Capaccio; Giovanni Murialdo; Carlo Martinoli
Relationship between fatty degeneration of thigh muscles and vitamin D status in the elderly: a preliminary MRI study.
AJR. American journal of roentgenology 2010;194(3):728-34.
2009: Matteo Puntoni; Andrea Decensi
The rationale and potential of cancer chemoprevention with special emphasis on breast cancer.
European journal of cancer (Oxford, England : 1990) 2009;45 Suppl 1():346-54.
2009: Silvia Zanardi; Matteo Puntoni; Massimo Maffezzini; Roberto Bandelloni; Marco Mori; Alessandra Argusti; Fabio Campodonico; Laura Turbino; Daniela Branchi; Rodolfo Montironi; Andrea Decensi
Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies.
Cancer prevention research (Philadelphia, Pa.) 2009;2(4):377-84.
2009: Barbara Maria Colombo; Fabio Cacciapaglia; Matteo Puntoni; Giuseppe Murdaca; Edoardo Rossi; Guido Rodriguez; Flavio Nobili; Livia Pisciotta; Stefano Bertolini; Tiziano Moccetti; Francesco Dentali; Luigi Steidl; Giorgio Ciprandi; Antonella Afeltra; Francesco Indiveri; Francesco Puppo
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study).
Autoimmunity reviews 2009;8(4):309-15.
2009: Matteo Puntoni; Bernardo Bonanni; Andrea Decensi
Dietary changes after breast cancer in women without hot flashes: a simple and inexpensive way to target tumor and host?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(3):323-5.
2008: Massimo Maffezzini; Giacomo Capponi; Stefania Casazza; Fabio Campodonico; Roberto Bandelloni; Matteo Puntoni
The UroVysion F.I.S.H. test compared to standard cytology for surveillance of non-muscle invasive bladder cancer.
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 2008;80(4):127-31.
2008: Matteo Puntoni; D Marra; S Zanardi; Andrea Decensi
Inflammation and cancer prevention.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 7():vii225-9.
2008: Gabriella Rondanina; Matteo Puntoni; Gianluca Severi; Clara Varricchio; Anna Zunino; Irene Feroce; Bernardo Bonanni; Andrea Decensi
Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1537-43.
2008: Alessandra Gennari; Maria Pia Sormani; Paolo Pronzato; Matteo Puntoni; Mariantonietta Colozza; Ulrich Pfeffer; Paolo Bruzzi
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
Journal of the National Cancer Institute 2008;100(1):14-20.
2007: Matteo Puntoni; Silvia Zanardi; Daniela Branchi; Silvia Bruno; Antonio Curotto; Marco Varaldo; Paolo Bruzzi; Andrea Decensi
Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(5):979-83.
2006: Silvia Zanardi; D Serrano; Alessandra Argusti; M Barile; Matteo Puntoni; Andrea Decensi
Clinical trials with retinoids for breast cancer chemoprevention.
Endocrine-related cancer 2006;13(1):51-68.
2006: Francesco Boccardo; Matteo Puntoni; Pamela Guglielmini; Alessandra Rubagotti
Enterolactone as a risk factor for breast cancer: a review of the published evidence.
Clinica chimica acta; international journal of clinical chemistry 2006;365(1-2):58-67.
2005: Francesco Boccardo; Alessandra Rubagotti; Matteo Puntoni; Pamela Guglielmini; Domenico Amoroso; Angela Fini; Giuseppe Paladini; Mario Mesiti; Domenico Romeo; Michela Rinaldini; Simona Scali; Mauro Porpiglia; Chiara Benedetto; Nunzio Restuccia; Franco Buzzi; Roberto Franchi; Bruno Massidda; Vito Distante; Dino Amadori; Piero Sismondi
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5138-47.
2005: riccardo puntoni; Marcello Ceppi; Claudia Casella; Donatella Ugolini; Valerio Gennaro; Matteo Puntoni; Marina Vercelli; Domenico Franco Merlo
Increased incidence of cutaneous malignant melanoma among longshoremen in Genoa, Italy: the role of sunlight and occupational exposure.
Occupational and environmental medicine 2005;62(4):270-1.
2005: Cristina Marenghi; Pamela Guglielmini; Elena Verri; Mariangela Parodi; Matteo Puntoni; Antonella Usset; Carola Massoni; Roberto Vormola; Francesco Boccardo
Impact of concurrent radiotherapy on chemotherapy total dose and dose intensity in patients with early breast cancer.
Tumori 2005;91(2):126-30.
2005: Elena Verri; Pamela Guglielmini; Matteo Puntoni; Luisa Perdelli; Andrea Papadia; Paola Lorenzi; Alessandra Rubagotti; Nicola Ragni; Francesco Boccardo
HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study.
Oncology 2005;68(2-3):154-61.
2004: riccardo puntoni; Marcello Ceppi; Valerio Gennaro; Donatella Ugolini; Matteo Puntoni; Gaspare La Manna; Claudia Casella; Domenico Franco Merlo
Occupational exposure to carbon black and risk of cancer.
Cancer causes & control : CCC 2004;15(5):511-6.
2003: riccardo puntoni; Matteo Puntoni; Marcello Ceppi
Re: Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.
Journal of the National Cancer Institute 2003;95(20):1552-3; author reply 1553-5.